DBV Technologies SA
PAR:DBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DBV Technologies SA
PAR:DBV
|
FR |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
|
NioCorp Developments Ltd
F:BR30
|
US |
|
C
|
Capita PLC
SWB:CTAA
|
UK |
|
H
|
Hextar Global Bhd
KLSE:HEXCARE
|
MY |
Wall St Price Targets
DBV Price Targets Summary
DBV Technologies SA
According to Wall Street analysts, the average 1-year price target for DBV is 5.202 EUR with a low forecast of 1.01 EUR and a high forecast of 9.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DBV's stock price target?
Price Target
5.202
EUR
According to Wall Street analysts, the average 1-year price target for DBV is 5.202 EUR with a low forecast of 1.01 EUR and a high forecast of 9.45 EUR.
What is the Revenue forecast for DBV Technologies SA?
Projected CAGR
376%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 376%.
What is the Gross Profit forecast for DBV Technologies SA?
Projected CAGR
462%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 462%.
